Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Nuclear Medicine

Free Subscription 01.12.2025 2 Ann Nucl Med 1 BMC Neurol 16 Clin Nucl Med 1 Hum Brain Mapp 7 J Nucl Cardiol 6 J Nucl Med 1 Neurology 3 Nucl Med Commun 2 Nuklearmedizin 1 Phys Med Biol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Nucl Med

1. SUKPRAKUN C, Tepmongkol S
   Diagnostic accuracy of brain perfusion SPECT parameters for seizure onset zone localization in drug-resistant epilepsy.
   Ann Nucl Med. 2025 Nov 25. doi: 10.1007/s12149-025-02128.
   PubMed        
   
   
2. LAI R, Jiang Z, Sheng D, Geng Y, et al
   Prognostic value of a combined model integrating clinical and PET radiomics parameters in metastatic melanoma: A dual-center retrospective study.
   Ann Nucl Med. 2025 Nov 22. doi: 10.1007/s12149-025-02133.
   PubMed         Abstract available
   
   

   
   BMC Neurol

3. TAKAI I, Ogawa T, Oji Y, Yayama A, et al
   Iatrogenic cerebral amyloid angiopathy 30 years after childhood cadaveric dura mater transplantation: a case report.
   BMC Neurol. 2025;25:486.
   PubMed         Abstract available
   
   

   
   Clin Nucl Med

4. KUMAR SA, Balgi V, Goyal H, Mishra S, et al
   Cardiac Somatostatin-receptor Expression Demonstrated by 68Ga DOTANOC PET/CT in a Child Presenting With Neuroblastoma and Presumed Catecholamine-induced Cardiomyopathy.
   Clin Nucl Med. 2025 Nov 7. doi: 10.1097/RLU.0000000000006196.
   PubMed         Abstract available
   
   
5. BEDMUTHA A, Barron B, Lau S, Oi K, et al
   Multiprobe PET Imaging: Insignia of Tumor Heterogeneity in a Case of Neuroendocrine Prostate Cancer.
   Clin Nucl Med. 2025 Oct 15. doi: 10.1097/RLU.0000000000006182.
   PubMed         Abstract available
   
   
6. PARGHANE RV, Yadav S, Saju A, Basu S, et al
   False-positive [68Ga]Ga-FAPI-04 PET/CT Following Treatment of 177Lu-DOTATATE PRRT in a Patient With Metastatic High-grade Well-differentiated Neuroendocrine Tumor.
   Clin Nucl Med. 2025 Oct 16. doi: 10.1097/RLU.0000000000006181.
   PubMed         Abstract available
   
   
7. ZHOU Z, Wen X, Xie P, Yang J, et al
   18F-FDG PET/CT Demonstrates Left Adrenal Neuroblastoma in a Pediatric Patient With Beckwith-Wiedemann Syndrome.
   Clin Nucl Med. 2025 Oct 28. doi: 10.1097/RLU.0000000000006190.
   PubMed         Abstract available
   
   
8. XIE H, Huang S, Li L
   Primary Intracranial Neuroendocrine Carcinoma Revealed by 18F-FDG PET/CT.
   Clin Nucl Med. 2025 Oct 29. doi: 10.1097/RLU.0000000000006198.
   PubMed         Abstract available
   
   
9. BALGI V, Kumar SA, Goyal H, Ganesan P, et al
   Unusual Skeletal Muscle Recurrence of Mantle Cell Lymphoma After Rituximab Maintenance Therapy Detected on 18F-FDG PET/CT.
   Clin Nucl Med. 2025 Oct 16. doi: 10.1097/RLU.0000000000006163.
   PubMed         Abstract available
   
   
10. DUTTA M, Jayanthi MR, G S, Haja A, et al
    Not All That Glows Is Cancer: Ga-68 FAPI PET/CT Uptake in Eosinophilic Esophagitis.
    Clin Nucl Med. 2025 Oct 16. doi: 10.1097/RLU.0000000000006164.
    PubMed         Abstract available
    
    
11. RAVADA SK, Parghane RV, Basu S
    Dichotomous Uptake Pattern on [18F]F-FDG and [68Ga]Ga-DOTA-FAPI-04 PET/CT in Lytic, Sclerotic and Marrow Metastatic Skeletal Lesions in Medullary Thyroid Carcinoma.
    Clin Nucl Med. 2025 Nov 3. doi: 10.1097/RLU.0000000000006206.
    PubMed         Abstract available
    
    
12. DHARMASHAKTU Y, Wakankar RN, Venugopal A, Kumar R, et al
    18F-FDG PET/CT Findings in an Atypical Case of Glial Fibrillary Acidic Protein Meningomyelitis.
    Clin Nucl Med. 2025 Nov 7. doi: 10.1097/RLU.0000000000005992.
    PubMed         Abstract available
    
    
13. SANDLER I, Armon-Omer A, Gelbstein N, Asla H, et al
    Hyperdense Pulmonary Artery Sign on Noncontrast CT: Definitive Diagnosis of High-burden Pulmonary Embolism by Lung Perfusion SPECT.
    Clin Nucl Med. 2025 Nov 26. doi: 10.1097/RLU.0000000000006237.
    PubMed         Abstract available
    
    
14. ZHANG B, Long Y, Yang T, Zhang Y, et al
    Clinical Utility of 18F-FDG PET/CT in Patients With Hypereosinophilia: An 11-year Single-center Experience.
    Clin Nucl Med. 2025 Oct 23. doi: 10.1097/RLU.0000000000006177.
    PubMed         Abstract available
    
    
15. ZHANG W, Xiao L, Zhou Y, Pan S, et al
    68Ga-FAPI-04 PET/CT in Renal NUT Carcinoma.
    Clin Nucl Med. 2025 Oct 23. doi: 10.1097/RLU.0000000000006188.
    PubMed         Abstract available
    
    
16. GUPTA S, Sonavane S, Yadav S, Basu S, et al
    Rare Site Colonic Metastasis in Renal Cell Carcinoma: Imaging Features on CECT and Multitracer PET-CT Employing 18F-FDG, 68Ga-FAPI-04, and 68Ga-PSMA-11.
    Clin Nucl Med. 2025 Oct 28. doi: 10.1097/RLU.0000000000006187.
    PubMed         Abstract available
    
    
17. WEN X, Li S, Xie P, Wang W, et al
    Unusual Initial Presentation of Epileptic Seizures in a Pediatric Patient With Neuroblastoma Detected by 18F-FDG PET/CT Imaging.
    Clin Nucl Med. 2025 Oct 28. doi: 10.1097/RLU.0000000000006174.
    PubMed         Abstract available
    
    
18. DRESCHER R, Schneider G, Senft C, Greiser J, et al
    Dural Injury Revealed by 64Cu-DOTA PET/CT Cisternography and Intraoperative Detection of a Cholesteatoma After a Temporal Bone Gunshot Injury.
    Clin Nucl Med. 2025 Oct 29. doi: 10.1097/RLU.0000000000006172.
    PubMed         Abstract available
    
    
19. HUANG D, Ji Y, Jiang C, Zhang C, et al
    Extensive Intravenous Tumor Thrombus and Right Atrial Bland Thrombus From Poorly Differentiated Thyroid Cancer: 18F-FDG PET/CT Imaging Findings.
    Clin Nucl Med. 2025 Oct 29. doi: 10.1097/RLU.0000000000006154.
    PubMed         Abstract available
    
    

    
    Hum Brain Mapp

20. FISHER PM, Larsen K, Plaven-Sigray P, Knudsen GM, et al
    Discordance Between Spatial and Population Correlations From Human Brain Imaging Data.
    Hum Brain Mapp. 2025;46:e70421.
    PubMed         Abstract available
    
    

    
    J Nucl Cardiol

21. ASSANTE R, Zampella E, D'Antonio A, Mannarino T, et al
    Improved risk stratification with non-invasive measures of myocardial flow reserve by low-dose dynamic imaging by CZT-SPECT in patients with suspected or known CAD.
    J Nucl Cardiol. 2025 Nov 20:102564. doi: 10.1016/j.nuclcard.2025.102564.
    PubMed        
    
    
22. NIELSEN MO, Lassen ML, Zerahn B, Kjaer A, et al
    Evaluation of Rest (82)Rb PET as an Alternative to (99m)Tc-Based Monitoring of Cardiac Function During Chemotherapy.
    J Nucl Cardiol. 2025 Nov 20:102567. doi: 10.1016/j.nuclcard.2025.102567.
    PubMed        
    
    
23. WANG K, Li X, Song S, Li H, et al
    Quantifying Right Ventricular Fibrosis Burden in CTEPH via FAPI SPECT/CT: Correlation with Echocardiographic Parameters and BPA Response.
    J Nucl Cardiol. 2025 Nov 20:102565. doi: 10.1016/j.nuclcard.2025.102565.
    PubMed         Abstract available
    
    
24. SPERRY BW, Godwin LA, Hutt E, Case JA, et al
    Quantitative Changes Between 1 and 3 hours in Technetium Pyrophosphate Cardiac Amyloid SPECT Imaging.
    J Nucl Cardiol. 2025 Nov 21:102568. doi: 10.1016/j.nuclcard.2025.102568.
    PubMed        
    
    
25. ZHANG D, Gu Y, Liu H, Ding D, et al
    Pharmacokinetic modelling of dynamic (99m)Tc-4BOH SPECT for myocardial perfusion imaging in patients with coronary artery disease.
    J Nucl Cardiol. 2025 Nov 21:102570. doi: 10.1016/j.nuclcard.2025.102570.
    PubMed         Abstract available
    
    
26. APHALE P, Shekhar H, Dokania S
    Refining Quantitative SPECT/CT in Transthyretin Cardiac Amyloidosis: Toward Standardized Clinical Application.
    J Nucl Cardiol. 2025 Nov 26:102571. doi: 10.1016/j.nuclcard.2025.102571.
    PubMed        
    
    
27. MILLER RJH, Shanbhag A, Shahi K, Bosley D, et al
    Artificial Intelligence-Driven Longitudinal Quantification of Technetium Pyrophosphate Uptake in Cardiac Amyloidosis: Correlation with Multimodality Imaging and Outcomes.
    J Nucl Cardiol. 2025 Nov 26:102573. doi: 10.1016/j.nuclcard.2025.102573.
    PubMed         Abstract available
    
    

    
    J Nucl Med

28. CHIOTIS K, Wang Y, La Joie R, Rabinovici GD, et al
    The Role of Amyloid-beta and Tau PET in the New Era of Alzheimer Disease Therapies.
    J Nucl Med. 2025 Nov 25:jnumed.124.268339. doi: 10.2967/jnumed.124.268339.
    PubMed         Abstract available
    
    
29. SCOTT PJH, VanBrocklin HF, Cumming RC, Dick DW, et al
    FDA Investigator Training for PET Drug Manufacturing Inspections.
    J Nucl Med. 2025 Nov 25:jnumed.125.271221. doi: 10.2967/jnumed.125.271221.
    PubMed        
    
    
30. BUCH-OLSEN KM, Vilstrup MH, Hansen S, Poulsen MH, et al
    Primary Staging of Intermediate- and High-Risk Prostate Cancer Using [(18)F]PSMA-1007 PET/CT and [(18)F]NaF PET/CT: A Head-to-Head Comparison of Diagnostic Accuracy, Staging, and Patient Management.
    J Nucl Med. 2025 Nov 25:jnumed.125.270710. doi: 10.2967/jnumed.125.270710.
    PubMed         Abstract available
    
    
31. HESSE L, Gillett D, MacFarlane J, Pirlich M, et al
    Comparative PET Imaging for Radiosurgical Target Delineation in Residual Acromegaly.
    J Nucl Med. 2025 Nov 25:jnumed.125.270365. doi: 10.2967/jnumed.125.270365.
    PubMed        
    
    
32. RAHMIM A, Bradshaw TJ, Davidzon G, Dutta J, et al
    Nuclear Medicine AI in Action: The Bethesda Report (AI Summit 2024).
    J Nucl Med. 2025 Nov 25:jnumed.125.269540. doi: 10.2967/jnumed.125.269540.
    PubMed         Abstract available
    
    
33. GABLER N, Kirchhoff S, Sauter A, Heck M, et al
    [(18)F]Flotufolastat PET/MRI in Patients with Suspected Prostate Cancer: Correlation with Histopathologic Biopsy Results.
    J Nucl Med. 2025 Nov 25:jnumed.125.270435. doi: 10.2967/jnumed.125.270435.
    PubMed         Abstract available
    
    

    
    Neurology

34. LIN M, Zeng Q, Zhong S, Nie S, et al
    Association Between Choroid Plexus Morphological Alterations, Alzheimer Pathologies, and Cognitive Impairment: A Longitudinal Study.
    Neurology. 2025;105:e213953.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

35. JAIN Y, Shukla V, Tripathi M, Venkatachalam M, et al
    Role of Gallium 68 fibroblast activation protein inhibitor PET/CT in the initial evaluation of gastric adenocarcinoma: a single-institution retrospective study.
    Nucl Med Commun. 2025 Nov 28. doi: 10.1097/MNM.0000000000002081.
    PubMed         Abstract available
    
    
36. NOH A, Thompson SR, Lehane C, Parasyn A, et al
    Fluoro-2-deoxy-d-glucose PET radiomic analysis predicts outcome in patients with soft tissue sarcoma.
    Nucl Med Commun. 2025 Nov 28. doi: 10.1097/MNM.0000000000002074.
    PubMed         Abstract available
    
    
37. HUANG YY, Huang KC, Lee PI
    Predicting hematologic toxicity of lutetium-177 prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer using pretreatment gallium-68 prostate-specific membrane antigen positron emission tomography imaging: prelim
    Nucl Med Commun. 2025 Nov 25. doi: 10.1097/MNM.0000000000002086.
    PubMed         Abstract available
    
    

    
    Nuklearmedizin

38. MONSEF A, Saboktakin F, Sadeghi F, Elhaie M, et al
    Experimental approach for optimizing dose regimen of 68Ga-DOTATATE PET/CT for neuroendocrine tumor (NET) imaging in current high sensitivity scanners: Phantom and Patient Study.
    Nuklearmedizin. 2025;64:341-351.
    PubMed         Abstract available
    
    
39. LINDNER O, Gutberlet M, Burchert W, Derlin T, et al
    Myocardial Perfusion SPECT 2024 in Germany: Results of the 10th Survey.
    Nuklearmedizin. 2025 Nov 24. doi: 10.1055/a-2738-2589.
    PubMed         Abstract available
    
    

    
    Phys Med Biol

40. NUYTS J, Defrise M, Morel C, Lecoq P, et al
    How the sensitivity of TOF-PET depends on the interplay between the temporal and spatial detector resolutions and the resolution required for the imaging task.
    Phys Med Biol. 2025 Nov 25. doi: 10.1088/1361-6560.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.